论文部分内容阅读
目的:观察应用思美泰治疗病毒性肝炎高胆红素血症的临床疗效。方法:选取2008年1月至2014年1月收治的168例病毒性肝炎高胆红素血症的患者为研究对象,将其分为对照组和观察组各84例,对照组使用还原型谷光苷肽注射液及复方甘草酸苷注射液配合治疗,观察组在对照组的基础上加用思美泰注射液进行治疗,对两组患者的治疗效果、治疗前后各生化指标改善情况、不良反应进行对比。结果:观察组治疗总有效率高于对照组(P<0.05);观察组与对照组治疗后各生化指标值比治疗前均降低(P<0.05),且观察组治疗后各生化指标值均低于对照组治疗后各生化指标值(P<0.05);两组均未观察到任何不良反应。结论:思美泰用于治疗高胆红素血症,疗效确切且有效率高,治疗前后各生化指标改善幅度高,不良反应低,值得临床推广运用。
Objective: To observe the clinical efficacy of Simei Thai in the treatment of viral hepatitis with hyperbilirubinemia. Methods: A total of 168 patients with viral hepatitis with hyperbilirubinemia who were admitted to our hospital from January 2008 to January 2014 were selected and divided into control group and observation group (n = 84). The control group was treated with reduced glutathione Glycoside peptide injection and compound glycyrrhizin injection with the treatment group, the observation group based on the control group plus Simmel injection, the treatment effect of two groups of patients before and after treatment to improve the biochemical indicators, adverse reactions comparing. Results: The total effective rate in the observation group was higher than that in the control group (P <0.05). The biochemical values of the observation group and the control group were lower than those before treatment (P <0.05), and the biochemical indexes Which was lower than that of the control group after treatment (P <0.05). No adverse reactions were observed in both groups. Conclusion: Simei Tai for the treatment of hyperbilirubinemia, the exact effect and high efficiency before and after treatment of various biochemical indicators of high range, low adverse reactions, it is worth promoting the use of clinical.